Season 2, Episode 21: A Century of X-Rays with Margaret Yu In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care. Dr. Yu unpacks the 130-year history of radiation in medicine — from the discoveries of Marie and Pierre Curie to the approval of modern alpha isotopes — and explains how ARTBIO is developing new rad...
All content for Pharmaverse Podcast is the property of Michael Pietrack and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Season 2, Episode 21: A Century of X-Rays with Margaret Yu In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care. Dr. Yu unpacks the 130-year history of radiation in medicine — from the discoveries of Marie and Pierre Curie to the approval of modern alpha isotopes — and explains how ARTBIO is developing new rad...
Season 2, Episode 2: Keys to Effective Leadership with Rob Abbott
Pharmaverse Podcast
30 minutes
9 months ago
Season 2, Episode 2: Keys to Effective Leadership with Rob Abbott
Welcome back to the Pharmaverse Podcast! In episode 2 of Season 2, our host Michael Pietrack interviews Rob Abbott, CEO of ISPOR, discussing the significance of Health Economics and Outcomes Research (HEOR) in the pharmaceutical industry. There is a LOT to learn here, so buckle up for a great episode! They explore ISPOR's role in influencing health policy, the implications of the Inflation Reduction Act, and the balance between drug affordability and innovation. Abbott emphasize...
Pharmaverse Podcast
Season 2, Episode 21: A Century of X-Rays with Margaret Yu In this powerful episode of the Pharmaverse Podcast, host Michael Pietrack sits down with Dr. Margaret Yu, Chief Medical Officer at ARTBIO, an oncology company leading the charge in Radioligand Therapy (RLT) to revolutionize cancer care. Dr. Yu unpacks the 130-year history of radiation in medicine — from the discoveries of Marie and Pierre Curie to the approval of modern alpha isotopes — and explains how ARTBIO is developing new rad...
